View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Abingdon Health

Near-Patient Testing to Guide Patient Therapy Pathways

Free White Paper

Near-Patient Testing to Guide Patient Therapy Pathways

By Abingdon Health

Near-Patient Testing to Guide Patient Therapy Pathways

By Abingdon Health
Enter your details to receive the free paper:

Monitoring patient response to therapeutics comes with a need to follow certain assessment and testing protocols.

Conventional central laboratory testing programs can be lengthy, possibly causing anxiety for patients and unnecessarily using up vital funds.

Diagnostic testing linked with pharmaceutical therapies and vaccines is increasing as public and private health budget managers seek to demonstrate the efficacy and value of chosen therapies.

Abingdon Health’s pedigree in lateral flow development and ability to assume legal manufacturer status on behalf of its customers expedites the development, manufacture and launch of a near-patient test. This presents a time and cost-efficient route to market and a long term assurance of post launch product support and continuity of supply.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology